Literature DB >> 2695738

Recently described innate broad spectrum virus inhibitors.

S Baron1, D Niesel, I P Singh, L McKerlie, J Poast, A Chopra, G Antonelli, F Dianzani, D H Coppenhaver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2695738      PMCID： PMC7135662          DOI： 10.1016/0882-4010(89)90042-9

Source DB:  PubMed          Journal:  Microb Pathog        ISSN： 0882-4010            Impact factor:   3.738


× No keyword cloud information.
  30 in total

1.  STUDIES OF ANTIVIRAL FACTORS IN HUMAN MILK AND SERUM.

Authors:  R H MICHAELS
Journal:  J Immunol       Date:  1965-02       Impact factor: 5.422

Review 2.  MECHANISM OF RECOVERY FROM VIRAL INFECTION.

Authors:  S BARON
Journal:  Adv Virus Res       Date:  1963       Impact factor: 9.937

3.  Viral inhibitors in normal animal sera.

Authors:  R ALLEN; R A FINKELSTEIN; S E SULKIN
Journal:  Tex Rep Biol Med       Date:  1958

4.  Antiviral activity in urine is attributable to ammonium salts.

Authors:  S Baron; J Sabados; M L McKerlie; D H Coppenhaver
Journal:  J Biol Regul Homeost Agents       Date:  1989 Apr-Jun       Impact factor: 1.711

5.  Characterization of an antiviral agent from primary murine fibroblast cultures: murine tissue culture CVI.

Authors:  M L Sullivan; D W Niesel; D H Coppenhaver; J Sabados; S Baron
Journal:  J Biol Regul Homeost Agents       Date:  1987 Jul-Sep       Impact factor: 1.711

6.  Studies on a heat-labile variola virus inhibitor in normal sera. II. Further characterization of the inhibitor and its activity.

Authors:  T Kitamura; Y Tanaka; M Sugané
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

7.  Nonspecific antiviral substances in human milk active against arbovirus and murine leukemia virus.

Authors:  A H Fieldsteel
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

8.  [An inhibitor of the replication of varicella-zoster virus].

Authors:  T Albrecht; M Zucca; F Dianzani
Journal:  G Ital Chemioter       Date:  1980 Jul-Dec

9.  Human coronavirus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay.

Authors:  G Gerna; E Cattaneo; P M Cereda; M G Revelo; G Achilli
Journal:  Proc Soc Exp Biol Med       Date:  1980-03

10.  Use of Semliki forest virus to identify lipid-mediated antiviral activity and anti-alphavirus immunoglobulin A in human milk.

Authors:  J K Welsh; I J Skurrie; J T May
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441
View more
  4 in total

1.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

2.  Innate gastrointestinal immunity: characterization of broadly active viral inhibitors.

Authors:  I P Singh; D H Coppenhaver; A K Chopra; S Baron
Journal:  Antiviral Res       Date:  2001-03       Impact factor: 5.970

Review 3.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

Review 4.  Innate defences against viraemia.

Authors:  I P Singh; S Baron
Journal:  Rev Med Virol       Date:  2000 Nov-Dec       Impact factor: 6.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.